The proposed mechanisms underlying such a beneficial protocol included anti-apoptosis and depression of Sost expression in osteoblasts by VK2, which partially counteracted ZA-reduced osteoblasts proliferation and mineralization inhibition, which in turn improved the osteoporosis therapeutic effects of ZA. Here, SOST is linked to osteoporosis.